S.C. Financial Services »

Brainstorm Cell Therapeutics shares owned by S.C. Financial Services

Quarter-by-quarter ownership of Brainstorm Cell Therapeutics shares owned by S.C. Financial Services from 13F filings

Historical chart of S.C. Financial Services investment in Brainstorm Cell Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Brainstorm Cell Therapeutics held by S.C. Financial Services consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Brainstorm Cell Therapeutics by S.C. Financial Services

Quarter filed Position value Share count Share price at filing
2022-12-31 $21k 13k 1.64
2022-06-30 $70k 26k 2.75
2022-03-31 $51k 15k 3.34
2021-12-31 $52k 15k 3.40

More positions owned by S.C. Financial Services

Apple (AAPL)
Ishares Tr Core S&p500 Etf (IVV)
Microsoft Corporation (MSFT)
Johnson & Johnson (JNJ)
Abbvie (ABBV)
First Tr Exchng Traded Fd Vi Tcw Opportunis (FIXD)
Ishares Tr Esg Awr Msci Usa (ESGU)
Exxon Mobil Corporation (XOM)
Abbott Laboratories (ABT)
First Tr Exchng Traded Fd Vi Cboe Vest Buferd (BUFT)
Procter & Gamble Company (PG)
Eli Lilly & Co. (LLY)
Home Depot (HD)
Pfizer (PFE)
Merck & Co (MRK)

View all positions for S.C. Financial Services